Novel paradigms for drug discovery: computational multitarget screening

Trends in Pharmacological Sciences
Ekachai JenwitheesukRam Samudrala

Abstract

An established paradigm in current drug development is (i) to identify a single protein target whose inhibition is likely to result in the successful treatment of a disease of interest; (ii) to assay experimentally large libraries of small-molecule compounds in vitro and in vivo to identify promising inhibitors in model systems; and (iii) to determine whether the findings are extensible to humans. This complex process, which is largely based on trial and error, is risk-, time- and cost-intensive. Computational (virtual) screening of drug-like compounds simultaneously against the atomic structures of multiple protein targets, taking into account protein-inhibitor dynamics, might help to identify lead inhibitors more efficiently, particularly for complex drug-resistant diseases. Here we discuss the potential benefits of this approach, using HIV-1 and Plasmodium falciparum infections as examples. We propose a virtual drug discovery 'pipeline' that will not only identify lead inhibitors efficiently, but also help minimize side-effects and toxicity, thereby increasing the likelihood of successful therapies.

Citations

Sep 6, 2008·Microbiology and Molecular Biology Reviews : MMBR·Gerald L NewtonRobert C Fahey
Jan 16, 2013·AIDS Research and Human Retroviruses·Maarten BuitendijkAlexandra L Howell
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Mark J Millan
Aug 26, 2011·Drug Discovery Today·Giovanni BottegoniAndrea Cavalli
Mar 8, 2011·Drug Discovery Today·Sean EkinsJoel S Freundlich
Aug 17, 2010·Drug Discovery Today·Pier G De Benedetti, Francesca Fanelli
May 27, 2009·The Lancet Infectious Diseases·Bruno GryseelsAnna Lönnroth
Apr 22, 2008·Current Opinion in Chemical Biology·Elisabet Gregori-Puigjané, Jordi Mestres
Nov 30, 2011·Biotechnology Journal·Hyun Uk KimSang Yup Lee
Apr 13, 2010·Bioorganic & Medicinal Chemistry·Filipe M AreiasJordi Mestres
Jul 2, 2014·Drug Discovery Today·Mark MinieRam Samudrala
Oct 23, 2009·FEMS Immunology and Medical Microbiology·Andrea CavalliMaria Laura Bolognesi
Jul 19, 2013·PLoS Computational Biology·Kai-Cheng HsuJinn-Moon Yang
May 24, 2014·Journal of Chemical Information and Modeling·Karen T SchomburgMatthias Rarey
Aug 8, 2013·Journal of Medicinal Chemistry·Jens-Uwe Peters
May 6, 2016·Journal of Biomolecular Screening·Justin K CraigWesley C Van Voorhis
Aug 18, 2012·Advances in Dental Research·J A HorstJ D B Featherstone
Oct 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·James SchulerRam Samudrala
Oct 22, 2008·Nature Chemical Biology·Andrew L Hopkins
Apr 2, 2010·Nature Reviews. Drug Discovery·Gisbert Schneider
Mar 29, 2018·Infectious Disorders Drug Targets·Yadira Lobaina, Yasser Perera
Nov 10, 2013·Cancers·Babu V SajeshKirk J McManus
Oct 12, 2018·Anti-cancer Agents in Medicinal Chemistry·Rabia HameedShagufta Perveen
Jun 9, 2019·BMC Research Notes·Zackary FallsRam Samudrala
Nov 30, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gaurav ChopraRam Samudrala
Jan 10, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·William Mangione, Ram Samudrala
Feb 20, 2010·Journal of Medicinal Chemistry·Richard Morphy
Jul 21, 2015·ACS Medicinal Chemistry Letters·Bryan D CoxDennis C Liotta
May 15, 2019·Journal of Medicinal Chemistry·Junting ZhouHaopeng Sun
Aug 18, 2021·Drug Discovery Today·James SchulerRam Samudrala

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.